Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.16 | N/A | -1.23% |
management commentary, guidance changes, and full analysis available with Pro.
| -1.23% |
Tone: Cautiously Optimistic
Overall, management expressed confidence in their strategic direction despite missing EPS expectations. They emphasized their commitment to innovation.
Management highlighted ongoing investments in innovation.
They noted a strong pipeline of products expected to drive future growth.
Boston Scientific's earnings report shows a slight miss on EPS, but the stock reacted positively, rising 2.45%. Investors may be encouraged by management's focus on innovation and future product pipelines. The lack of revenue data and guidance leaves some uncertainty, but the positive stock reaction suggests confidence in the company's long-term strategy.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERIPRISE FINL INC
Apr 22, 2013